Publikationen von Joanna Napp

Napp, J.; Markus, M. A.; Heck, J. G.; Dullin, C.; Möbius, W.; Gorpas, D.; Feldmann, C.; Alves, F.: Therapeutic fluorescent hybrid nanoparticles for traceable delivery of glucocorticoids to inflammatory sites. Theranostics 8 (22), S. 6367 - 6383 (2018)

Napp, J.; Stammes, M. A.; Claussen, J.; Prevoo, H. A. J. M.; Sier, C. F. M.; Hoeben, F. J. M.; Robillard , M. S.; Vahrmeijer, A. L.; Devling, T.; Chan, A. B. et al.; Geus-Oei, L.-F. d.; Alves, F.: Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma. International Journal of Cancer 142 (10), S. 2118 - 2129 (2018)

Neumeier, B. L.; Khorenko, M.; Alves, F.; Goldmann, O.; Napp, J.; Schepers, U.; Reichardt, H. M.; Feldmann, C.: Fluorescent inorganic-organic hybrid nanoparticles. ChemNanoMat 4, S. 1 - 23 (2018)

Poß, M.; Tower, R. J.; Napp, J.; Appold, L. C.; Lammers, T.; Alves, F.; Glüer, C.-C.; Boretius, S.; Feldmann, C.: Multimodal [GdO]+[ICG]- nanoparticles for optical, photoacoustic, and magnetic resoance imaging. Chemistry of Materials 29 (8), S. 3547 - 3554 (2017)

Pauli, J.; Pochstein, M.; Haase, A.; Napp, J.; Luch, A.; Resch-Genger, U.: Influence of label and charge density on the association of the therapeutic monoclonal antibodies Trastuzumab and Cetuximab conjugated to anionic fluorophores. ChemBioChem: A European Journal of Chemical Biology 18 (1), S. 101 - 110 (2017)

Giannuzzo, A.; Saccomano, M.; Napp, J.; Ellegaard, M.; Alves, F.; Novak, I.: Targeting of the P2X7 receptor in pancreatic cancer and stellate cells. International Journal of Cancer 139 (11), S. 2540 - 2552 (2016)

Napp, J.; Pardo, L. A.; Hartung, F.; Tietze, L. F.; Stühmer, W.; Alves, F.: In vivo imaging of tumour xenografts with an antibody targeting the potassium channel Kν10.1. European Biophysics Journal 45 (7), S. 721 - 733 (2016)

Saccomano, M.; Dullin, C.; Alves, F.; Napp, J.: Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery. International Journal of Cancer 139 (10), S. 2277 - 2289 (2016)

Poß, M.; Napp, J.; Niehaus, O.; Pöttgen, R.; Alves, F.; Feldmann, C.: M³⁺[amaranth]³⁻(M = La, Gd): a novel sulfonate-based inorganic-organic hybrid nanomaterial for multimodal imaging. Journal of Materials Chemistry C 3, S. 3860 - 3868 (2015)

Dullin, C.; dal Monego, S.; Larsson, E.; Mohammadi, S.; Krenkel, M.; Garrovo, C.; Biffi, S.; Lorenzon, A.; Markus , A.; Napp, J. et al.; Salditt, T.; Accardo, A.; Alves, F.; Tromba, G.: Functionalized synchrotron in-line phase-contrast computed tomography: a novel approach for simultaneous quantification of structural alterations and localization of barium-labelled alveolar macrophages within mouse lung samples. Journal of Synchrotron Radiation 22, S. 143 - 155 (2015)

Dullin, C.; dal Monego, S.; Larsson, E.; Mohammadi, S.; Krenkel, M.; Garrovo, C.; Biffi, S.; Lorenzon, A.; Markus, M. A.; Napp, J. et al.; Salditt, T.; Accardo, A.; Alves, F.; Tromba, G.: Functionalized synchrotron in-line phase-contrast computed tomography: a novel approach for simultaneous quantification of structural alterations and localization of barium-labelled alveolar macrophages within mouse lung samples. Journal of Synchrotron Radiation 22, S. 143 - 155 (2015)

Heck, J. G.; Napp, J.; Simonato, S.; Möllmer, J.; Lange, M.; Reichardt, H. M.; Staudt, R.; Alves, F.; Feldmann, C.: Multifunctional phosphate-based inorganic-organic hybrid nanoparticles. Journal of the American Chemical Society 137 (23), S. 7329 - 7336 (2015)

Markus, M. A.; Napp, J.; Behnke, T.; Mitkovski, M.; Monecke, S.; Dullin, C.; Kilfeather, S.; Dressel, R.; Resch-Genger, U.; Alves, F.: Tracking of Inhaled Near-Infrared Fluorescent Nanoparticles in Lungs of SKH-1 Mice with Allergic Airway Inflammation. ACS Nano 9, S. 11642 - 11657 (2015)

Mathejczyk, J. E.; Pauli, J.; Dullin, C.; Resch-Genger, U.; Alves, F.; Napp, J.: High-sensitivity detection of breast tumors in vivo by use of a pH-sensitive near-infrared fluorescence probe. Journal of Biomedical Optics 18 (8), 089801 (2013)

Behnke, T.; Mathejczyk, J. E.; Brehm, R.; Würth, C.; Ramos Gomes, F.; Dullin, C.; Napp, J.; Alves, F.; Resch-Genger, U.: Target-specific nanoparticles containing a broad band emissive NIR dye for the sensitive detection and characterization of tumor development. Biomaterials 34 (1), S. 160 - 170 (2013)

Wottawa, M.; Leisering, P.; Ahlen, M. v.; Schnelle, M.; Vogel, S.; Malz, C.; Bordoli, M. R.; Camenisch, G.; Hesse, A.; Napp, J. et al.; Alves, F.; Kristiansen, G.; Farhat, K.; Katschinski, D. M.: Knockdown of prolyl-4-hydroxylase domain 2 inhibits tumor growth of human breast cancer MDA-MB-231 cells by affecting TGF-β1 processing. International Journal of Cancer 132 (12), S. 2787 - 2798 (2013)

Napp, J.; Behnke, T.; Fischer, L.; Würth, C.; Wottawa, M.; Katschinski, D. M.; Alves, F.; Resch-Genger, U.; Schäferling, M.: Targeted luminescent near-infrared polymer-nanoprobes for in vivo imaging of tumor hypoxia. Analytical Chemistry 83 (23), S. 9039 - 9046 (2011)

Napp, J.; Mathejczyk, J. E.; Alves, F.: Optical imaging in vivo with a focus on pediatric disease: technical progress, current preclinical and clinical applications and future perspectives. Pediatric Radiology 41, S. 161 - 175 (2011)

Napp, J.; Dullin, C.; Müller, F.; Uhland, K.; Petri, J. B.; van de Locht, A.; Steinmetzer, T.; Alves, F.: Time-domain in vivo near infrared fluorescence imaging for evaluation of matriptase as a potential target for the development of novel, inhibitor-based tumor therapies. International Journal of Cancer 127 (8), S. 1958 - 1974 (2010)

Alves, F.; Dullin, C.; Napp, J.; Missbach-Guentner, J.; Jannasch, K.; Mathejczyk, J.; Pardo, L. A.; Stühmer, W.; Tietze, L.-F.: Concept of a selective tumour therapy and its evaluation by near-infrared fluorescence imaging and flat-panel volume computed tomography in mice. European Journal of Radiology 70 (2), S. 286 - 293 (2009)